<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04839419</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A02866-51</org_study_id>
    <nct_id>NCT04839419</nct_id>
  </id_info>
  <brief_title>Obesity-hypoventilation in Metabolic Syndrom Patients</brief_title>
  <official_title>PREVALENCE OF OBESITY-HYPOVENTILATION SYNDROME IN PATIENTS WITH METABOLIC SYNDROME</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SOS Oxygene Mediterranee</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SOS Oxygene Mediterranee</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome&#xD;
      in patients with metabolic syndrom.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After being informed about the study and potential risks, patient agreed to participate and&#xD;
      undergo :&#xD;
&#xD;
      a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled&#xD;
      with a capnography during the same night.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Capnia</measure>
    <time_frame>Up to one mont after inclusion</time_frame>
    <description>Arterial pression in CO2 and transcutaneous pression in CO2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial pression in CO2</measure>
    <time_frame>At the inclusion</time_frame>
    <description>PaCO2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>BMI</measure>
    <time_frame>At the inclusion</time_frame>
    <description>body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial pression in oxygen</measure>
    <time_frame>At the inclusion</time_frame>
    <description>PaO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>somnolence</measure>
    <time_frame>At the inclusion</time_frame>
    <description>EPWORTH questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity level</measure>
    <time_frame>At the inclusion</time_frame>
    <description>Ricci&amp;Gagnon questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood bicarbonates</measure>
    <time_frame>At the inclusion</time_frame>
    <description>HCO3-</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gases</measure>
    <time_frame>At the inclusion</time_frame>
    <description>pH</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hemoglobin</measure>
    <time_frame>At the inclusion</time_frame>
    <description>Hb</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>obstructive sleep apnea items</measure>
    <time_frame>Up to one mont after inclusion</time_frame>
    <description>Apnea-hypopnea index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Night Oxygen saturation</measure>
    <time_frame>Up to one mont after inclusion</time_frame>
    <description>SpO2</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <condition>Capnography</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be selected as part of their usual care, during a consultation for their&#xD;
        respiratory and metabolic monitoring.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  BMI&gt;30 kg/m2&#xD;
&#xD;
          -  no treatment with CPAP nor NIV&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  obstructive respiratory disease&#xD;
&#xD;
          -  non-treated cardiac dysfunction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu Despeaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique du Chateau de Vernhes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Delphine Delample, PhD</last_name>
    <phone>0612155648</phone>
    <phone_ext>+33</phone_ext>
    <email>d.delample@sosoxygene.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique du Ch√¢teau de Vernhes</name>
      <address>
        <city>Bondigoux</city>
        <zip>31340</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathieu Despeaux, MD</last_name>
      <phone>0561372727</phone>
      <phone_ext>+33</phone_ext>
      <email>m.despeaux@cliniquevernhes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 1, 2021</study_first_submitted>
  <study_first_submitted_qc>April 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2021</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

